FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022185726> ?p ?o ?g. }

• W3022185726 endingPage "2244" @default.
• W3022185726 startingPage "2232" @default.
• W3022185726 abstract "Optimized physical properties (e.g., bulk, surface/interfacial, and mechanical properties) of active pharmaceutical ingredients (APIs) are key to the successful integration of drug substance and drug product manufacturing, robust drug product manufacturing operations, and ultimately to attaining consistent drug product critical quality attributes. However, an appreciable number of APIs have physical properties that cannot be managed via routes such as form selection, adjustments to the crystallization process parameters, or milling. Approaches to control physical properties in innovative ways offer the possibility of providing additional and unique opportunities to control API physical properties for both batch and continuous drug product manufacturing, ultimately resulting in simplified and more robust pharmaceutical manufacturing processes. Specifically, diverse opportunities to significantly enhance API physical properties are created if allowances are made for generating co-processed APIs by introducing nonactive components (e.g., excipients, additives, carriers) during drug substance manufacturing. The addition of a nonactive coformer during drug substance manufacturing is currently an accepted approach for cocrystals, and it would be beneficial if a similar allowance could be made for other nonactive components with the ability to modify the physical properties of the API. In many cases, co-processed APIs could enable continuous direct compression for small molecules, and longer term, this approach could be leveraged to simplify continuous end-to-end drug substance to drug product manufacturing processes for both small and large molecules. As with any novel technology, the regulatory expectations for co-processed APIs are not yet clearly defined, and this creates challenges for commercial implementation of these technologies by the pharmaceutical industry. The intent of this paper is to highlight the opportunities and growing interest in realizing the benefits of co-processed APIs, exemplified by a body of academic research and industrial examples. This work will highlight reasons why co-processed APIs would best be considered as drug substances from a regulatory perspective and emphasize the areas where regulatory strategies need to be established to allow for commercialization of innovative approaches in this area." @default.
• W3022185726 created "2020-05-13" @default.
• W3022185726 creator A5009947666 @default.
• W3022185726 creator A5011151975 @default.
• W3022185726 creator A5022674925 @default.
• W3022185726 creator A5026914834 @default.
• W3022185726 creator A5029483875 @default.
• W3022185726 creator A5031793986 @default.
• W3022185726 creator A5040029620 @default.
• W3022185726 creator A5051842247 @default.
• W3022185726 creator A5056959076 @default.
• W3022185726 creator A5075627997 @default.
• W3022185726 creator A5079470042 @default.
• W3022185726 creator A5084307487 @default.
• W3022185726 creator A5090330136 @default.
• W3022185726 date "2020-05-11" @default.
• W3022185726 modified "2023-10-18" @default.
• W3022185726 title "Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies" @default.
• W3022185726 cites W1952143456 @default.
• W3022185726 cites W1965396305 @default.
• W3022185726 cites W1965580055 @default.
• W3022185726 cites W1965848391 @default.
• W3022185726 cites W1968726150 @default.
• W3022185726 cites W1970129214 @default.
• W3022185726 cites W1974856533 @default.
• W3022185726 cites W1977995411 @default.
• W3022185726 cites W1978963124 @default.
• W3022185726 cites W1980226338 @default.
• W3022185726 cites W1981760279 @default.
• W3022185726 cites W1986149672 @default.
• W3022185726 cites W1986769022 @default.
• W3022185726 cites W1987137315 @default.
• W3022185726 cites W1990663620 @default.
• W3022185726 cites W1993192593 @default.
• W3022185726 cites W1998604003 @default.
• W3022185726 cites W2001025570 @default.
• W3022185726 cites W2001996035 @default.
• W3022185726 cites W2004282507 @default.
• W3022185726 cites W2006932065 @default.
• W3022185726 cites W2010611271 @default.
• W3022185726 cites W2012000782 @default.
• W3022185726 cites W2012340637 @default.
• W3022185726 cites W2014107273 @default.
• W3022185726 cites W2018454401 @default.
• W3022185726 cites W2021713550 @default.
• W3022185726 cites W2022288348 @default.
• W3022185726 cites W2024241933 @default.
• W3022185726 cites W2024483780 @default.
• W3022185726 cites W2026448258 @default.
• W3022185726 cites W2027440437 @default.
• W3022185726 cites W2027674956 @default.
• W3022185726 cites W2031004189 @default.
• W3022185726 cites W2031493407 @default.
• W3022185726 cites W2040608810 @default.
• W3022185726 cites W2043658704 @default.
• W3022185726 cites W2049353843 @default.
• W3022185726 cites W2050639097 @default.
• W3022185726 cites W2054757178 @default.
• W3022185726 cites W2059682409 @default.
• W3022185726 cites W2060992818 @default.
• W3022185726 cites W2061864998 @default.
• W3022185726 cites W2061952624 @default.
• W3022185726 cites W2065295334 @default.
• W3022185726 cites W2070545569 @default.
• W3022185726 cites W2073010988 @default.
• W3022185726 cites W2073846631 @default.
• W3022185726 cites W2076111926 @default.
• W3022185726 cites W2077118360 @default.
• W3022185726 cites W2077908415 @default.
• W3022185726 cites W2079234186 @default.
• W3022185726 cites W2079574505 @default.
• W3022185726 cites W2081033495 @default.
• W3022185726 cites W2084153391 @default.
• W3022185726 cites W2086732824 @default.
• W3022185726 cites W2087644924 @default.
• W3022185726 cites W2089380906 @default.
• W3022185726 cites W2104080740 @default.
• W3022185726 cites W2105379243 @default.
• W3022185726 cites W2108405555 @default.
• W3022185726 cites W2111474748 @default.
• W3022185726 cites W2126528763 @default.
• W3022185726 cites W2130531669 @default.
• W3022185726 cites W2131297821 @default.
• W3022185726 cites W2131367176 @default.
• W3022185726 cites W2136510151 @default.
• W3022185726 cites W2136734302 @default.
• W3022185726 cites W2137386234 @default.
• W3022185726 cites W2142229269 @default.
• W3022185726 cites W2151678885 @default.
• W3022185726 cites W2158932701 @default.
• W3022185726 cites W2166437216 @default.
• W3022185726 cites W2167492210 @default.
• W3022185726 cites W2196471919 @default.
• W3022185726 cites W2223865210 @default.
• W3022185726 cites W2313661923 @default.
• W3022185726 cites W2321893261 @default.
• W3022185726 cites W2326560381 @default.
• W3022185726 cites W2327528487 @default.

• next